ENDO 2023 Session Recordings
Image For Activity Cover
14 Courses
Expires on Dec 31, 2025
Member: $249.00
Non-Member: $399.00
In-Training Member: $149.00
Resident Member: $149.00
Resident Non-Member: $399.00
Credit Offered
222.25 AMA PRA Category 1 Credits
222.25 Participation Credits
  • Course Description
  • Target Audience
  • Learning Objectives
  • Accreditation Statement
  • Faculty and Disclosures
  • Recommended
ENDO is the seminal meeting in hormone health and science, welcoming leading experts, researchers, and the most respected clinicians in the field as we share the latest developments in endocrine research and patient care.

Credit claiming will be done at the individual session level. Once you have watched all sessions for which you wish to claim credit, you may proceed to the evaluation to obtain a certificate.

For any credit types you do not wish to claim, simply click "Waive Credit".
ENDO 2023 is intended for the community of practitioners and clinicians who care for patients with hormone disorders as well as scientists advancing endocrine research.

Upon completion of this virtual course, learners should be able to: 

  • Discuss state-of-the-art research in endocrinology.
  • Practice updated clinical skills for more effective diagnosis, management, and treatment of endocrine disorders and related sequelae.
  • Apply updated knowledge and clinical skills in improving patient care.
  • Construct new research questions based on updated scientific and clinical advances in endocrinology related disciplines

The Endocrine Society is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. Endocrine Society has achieved Accreditation with Commendation.

AMA PRA Category 1 Credit
The Endocrine Society designates each activity in this course for a maximum of 223.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. While offering CME credits noted above, this program is not intended to provide extensive training or certification in the field.

Please note that while other accrediting bodies accept AMA PRA Category 1 credit, we can only award and report this credit for MDs/DOs. For those outside of this accreditation, please complete the participation evaluation and use that certificate as proof of attendance to submit to your accrediting body.

For questions about content or obtaining CME credit, please contact the Endocrine Society at info@endocrine.org

As a provider of CME accredited by the Accreditation Council for Continuing Medical Education, the Endocrine Society has a policy of ensuring that the content and quality of this educational activity are balanced, independent, objective, and scientifically rigorous. The scientific content of this activity was developed under the supervision of the Endocrine Society’s guideline task force.

The faculty, committee members, and staff who are in position to control the content of this activity are required to disclose to the Endocrine Society and to learners any relevant financial relationship(s) of the individual or spouse/partner that have occurred within the last 12 months with any commercial interest(s) whose products or services are related to the content. Financial relationships are defined by remuneration in any amount from the commercial interest(s) in the form of grants; research support; consulting fees; salary; ownership interest (e.g., stocks, stock options, or ownership interest excluding diversified mutual funds); honoraria or other payments for participation in speakers' bureaus, advisory boards, or boards of directors; or other financial benefits. The intent of this disclosure is not to prevent planners with relevant financial relationships from planning or delivery of content, but rather to provide learners with information that allows them to make their own judgments of whether these financial relationships may have influenced the educational activity with regard to exposition or conclusion.

The following AMSC members reported relevant financial relationships:

  • Irina Bancos, MD, Advisory Board: Adrenas, HRA Pharma, Corcept, Recordati, Consulting: HRA Pharma, Corcept, Sparrow Pharmaceutics, Recordati, Writer: Elsevier, Funding for Investigator Initiated Award: Recordati, NIH, Reviewer: Dynamed 
  • Andrew Bauer, MD, Speaker: Hexal, AG 
  • Denise D. Belsham, PhD, President: Pan American Neuroendocrine Society 
  • Kristien Boelaert, MD, PhD, Advisory Board: Pfizer, EISAI; Member and Awards Committee: American Thyroid Association; Member, Council Member, Clinical Committee Chair Elect: Society for Endocrinology; Member: British Thyroid Association, European Thyroid Association, European Endocrine Society, British Thyroid Association 
  • Massimiliano Caprio, MD, PhD, Grant Recipient: Bayer AG; Associate Editor: Frontiers in Endocrinology 
  • Barbara Gisella Carranza Leon, MD, Co-investigator: Novartis, IONIS Phamaceutical Inc, NIH, FH Foundation, Regenxbio, Inc.; Member of the Maintenance of Certification Committee: American Board of Obesity Medicine 
  • Bart L. Clarke, MD, Advisory Board: Bristol-Myers Squibb; Consulting Fee: Shire/Takeda, Inc., Calcilytix, Inc., Amolyt, Inc., Entera Bio, Extend Bio, ShouTi Pharma; Site Principal Investigator: Shire/Takeda, Inc., Ascendis, Inc., Chugai, Inc. 
  • Carolyn L. Cummins, PhD, Member: American Association of Pharmaceutical Scientists, Canadian Society of Pharmaceutical Sciences; Reviewer and Grantee: Canadian Institutes of Health Research 
  • Aime T. Franco, PhD, Advisory Board: American Thyroid Association  
  • Daniel E. Frigo, PhD, Consultant and Grant Recipient: GTx, Inc. 
  • Adda Grimberg, MD, Advisory Board: Pfizer, Consultant: Pediatric Endocrine Society Growth Hormone Deficiency Knowledge Center, Sponsored by Sandoz; Grant Recipient: Eunice Kennedy Shriver National Institute of Child Health and Human Development; Advisory Board: Pediatric Endocrine Society, Growth Hormone Research Society, Editorial Board: Pediatric Endocrinology Reviews; Speaker: Midwest Pediatric Endocrine Society, Canadian Pediatric Endocrine Group 
  • Ole-Petter Hamnvik, MBBChBAO, MMSc, MRCPI, Education Editor: New England Journal of Medicine 
  • Shingo Kajimura, PhD, Editorial Activities: Molecular Metabolism, Molecular and Cellular Biology, Journal of Clinical Investigation Insight, Life Science Alliance, Reviewer: NIDDK, Research Support: Daiichi Sankyo Inc., Ltd, Calico Life Sciences LLC.  
  • Marta Korbonits, MD, PhD, Speaker: Pfizer, Ipsen; Associate Editor: JES, Endocrine Society; Scientific Advisor: ONO, NorvoNordisk, Corcept; Investigator: Crinetics 
  • Monica M. Laronda, PhD, Advisory Board Member: Dimension Inx; Section Editor: Reproductive Biomedicine Online (RBMO) 
  • Ellis R. Levin, MD, Stock Owner: Gilead Inc., Amgen 
  • Christopher McCartney, MD, Grant Recipient: NIH, Reviewer: NIH 
  • Raghavendra Mirmira, PhD, MD, Editor: Journal of Clinical Endocrinology and Metabolism, Advisory Board: Veralox Therapeutics, Investigator-Initiated Award: Veralox Therapeutics, HiberCell, Inc. 
  • Erik Russell Nelson, BSc, PhD, Member: American Physiological Society, American Association for Cancer Research, American Association for the Advancement of Science 
  • Gabrielle Page-Wilson, MD, Advisory Board: Strongbridge Biopharma, Recordati Rare Diseases, Inc., Xeris BioPharma; Consultant: Xeris BioPharma 
  • Yumie Rhee, MD, PhD, Ambassador: American Society of Bone and Mineral Research, Committee: Korean Endocrine Society, Korean Society of Bone and Mineral Research 
  • Stephen Rosenthal, MD, Board of Directors and Member: World Professional Association for Transgender Health 
  • Jenny A. Visser, PhD, Member: Dutch Endocrine Society (NVE), European Endocrine Society (ESE), Women in Endocrinology (WE), Organisation for the Study of Sex Differences (OSSD), Advisory Board: European Endocrine Society (ESE), Editorial Board: Frontiers in Endocrinology, Metabolism, Associate Editor: Human Reproduction Update 
  • W. Edward Visser, MD, PhD, Royalties (Institution): Egetis Therapeutics 
  • Bu Beng Yeap, MBBS, FRACP, PhD, Advisory Board: NovoNordisk, Bayer, Advisor: Lawley Pharmaceuticals, Speaker: AstraZeneca, Besins, Philippine Society for Endocrinology, Diabetes and Metabolism, View Street Medical, President: Endocrine Society of Australia, Associate Editor: Asian Journal of Andrology, Journal of Gerontology Medical Sciences, Editorial Board: Journal of Gerontology Medical Sciences, Journal of Clinical Endocrinology and Metabolism, Maturitas 
  • Elaine Wei-Yin Yu, MD, Grant Recipient: Amgen, Stock Owner: Opko 
  • Maria-Christina  Zennaro, MD, PhD, Member: Societé Française d'Endocrinology, Societé Française de Caridologie, European Network for the Study of Adrenal Tumors; Executive Committee: International Aldosterone Conference; President: European Section of Aldosterone Council (ESAC)-France; French network on adrenal tumors COMETE 

    The following AMSC members reported no relevant financial relationships: 

Ana Paula Abreu, MD, PhDBenson Akingbemi, PhD, DVM; Ernesto Bernal-Mizrachi, MD; Davide Calebiro, MD; Jaydira Del Rivero, MD; T. Raj Kumar, PhD, MPHIL, MSC; Claire Newton, BSc, PhD; Matti Poutanen, PhD; Kimia Saleh Anaraki, MD; and Marc J. Tetel, PhD

Disclosure information for presenters is included in their individual recorded presentations.

Endocrine Society staff associated with the development of content for this activity reported no relevant financial relationships.

     EndoCareers | Contact Us | Privacy Policy | Terms of Use CONNECT WITH US                
       © 2021 Copyright Endocrine Society. All rights reserved.
2055 L Street NW, Suite 600 | Washington, DC 20036      
 202.971.3636 | 888.363.6274
Android App Download IOS App Download Powered By